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From April 1991 to January 1993, 37 orthotopic heart transplantations 
were performed at our institution. Conventional preservation technique 
with cold crystalloid cardioplegia and topical hypothermia during storage 
and implantation was used in the first 15 cases (group A). After January 
1992, for the next 22 patients (group B), we administered a first dose of 
hyperkalemic blood cardioplegia on arrival of the graft and thereafter 
instituted continuous warm reperfusion by infusion of oxygenated blood 
with added potassium. The groups were compared retrospectively, and 
significant differences were observed. In group B, the ischemic time was 
shortened by 31 minutes, the suture time lasted 12 minutes longer, sinus 
rhythm recovered spontaneously, the duration of inotropic support was 
reduced, postoperative arrythmias decreased, length of intensive care and 
hospital stays were reduced, there was less ischemic damage in the first 
endomyocardial biopsy sample, and right ventricular pressures a month 
after operation were lower. Continuous warm reperfusion during implan- 
tation of the donor heart is technically feasible and seems to provide 
enhanced myocardial preservation. (J TItORAC CARDIOVASC SURG 1996;111: 
784-90) 
H igh hospital mortality rates from primary graft failure (25% of all deaths) 1 and more frequent 
use of "suboptimum" donors because of the scarcity 
of donor organs 2 have caused renewed interest in 
perfecting cardiac preservation techniques 3 during 
heart transplantation. Even in uncomplicated heart 
transplantation, it is possible during the first 24 to 48 
hours after operation to observe transitory hemody- 
namic and electrical instability. 4' 5 When this tempo- 
rary phenomenon occurs in hearts with previously 
normal function, it is attributable toa certain degree 
of myocardial "stunning. ''6-9 
In a recent survey, Wheeldon and coworkers 3 
observed that some form of reperfusion is used in 
55% of 92 transplant centers worldwide. Most of 
these centers infuse intermittent doses of cold blood 
or cold oxygenated crystalloid cardioplegia during 
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implantation of the heart and thereafter administer 
normothermic blood reperfusion doses ("hot shots") 
according to Buckberg's preservation technique. 1°-13 
In contrast, Menasch614 uses continuous normo- 
thermic blood cardioplegia fter completion of the 
left atrial anastomosis, a technique derived from the 
"warm surgery" principles recently introduced by 
Salerno, Houck, and Barrozo. 15 
We employed the conventional preservation tech- 
nique (cold crystalloid cardioplegia nd cold stor- 
age)16, 17 until January 1992. Thereafter we devel- 
oped our own technique of reperfusion, combining 
Buckberg's theories to reduce reperfusion dam- 
age 18-2° with continuous normothermic blood car- 
dioplegia to oxygenate and supply the metabolic 
requirements of the myocardial cells under normo- 
thermia, thereby attempting some degree of cellular 
repair.15,21, 22 In this article, we describe the new 
technique and results of a retrospective comparative 
analysis of these two techniques of donor heart 
preservation. 
Materials and methods 
From April 1991 to January 1993, 37 orthotopic heart 
transplantations were performed at our institution. In the 
first 15 cases (group A), until December 1991, a conven- 
tional preservation technique was employed, with the 
infusion of 1000 ml of extracellular c ystalloid cardiople- 
gia (30 mEq/L potassium chloride) at 4 ° C for induction of 
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Table I. Cardioplegic solutions 
Induction Reperfitsion 
(2 mEq/ml) Potassium 15 40 
chloride solution (ml) 
Potassium chloride sol- 30 80 
ute (mEq) 
0.3 mol/L THAM solu- - -  225 
tion (ml) 
THAM solute (mEq) 68 
CPD (ml) - -  225 
Aspartate/glutamate (ml) - -  250 
5% dextrose (ml) - -  200 
50% dextrose (ml) - -  40 
Sodium chloride (mEq) 82 - -  
Calcium chloride (mEq) 0.5 - -  
Glucose (gm) 5 - -  
Mannitol (gin) 10 - -  
NaCO3H 1 mol/L (ml) 30 - -  
Injectable water q.s. - -  
pH 8.6 8.26 
Osmolarity (mOsm) 369 627 
Total volume (ml) 1000 1000 
THAM, Tris(hydroxyrnethyl)aminomethane; CPD, citrate-phosphate-dex- 
trose solution; q.s., a sufficient quantity. 
cardiac arrest (Table I), subsequent transportation a d 
storage with the same cardioplegic solution at 4 ° C, local 
hypothermia during implantation, and systemic tempera- 
ture of 28 ° C during extracorporeal circulation. 
Since January 1992, in the last 22 transplant cases 
(group B), the same solution and dosage of crystalloid 
cardioplegia were used for induction of cardiac arrest and 
transportation. While extracorporeal circulation was es- 
tablished with hypothermia at32 ° to 34 ° C and the recip- 
ient heart was being removed, the donor heart was 
removed from the refrigerator and trimmed as usual for 
implantation atroom temperature. 
The aortic root of the donor was stappled just distal to 
the brachiocephalic trunk with the Multifire TA 55-4.8 
stapler (United States Surgical Corp., Norwalk, Conn.) 
and an aortic root cannula (model 10012, DLP Inc., 
Grand Rapids, Mich.) was positioned in the ascending 
aorta. At this moment, antegrade r perfusion of the heart 
was begun with a (4:1) solution of blood cardioplegia, 
Buckberg type, at 30 ° or 32°C during 5 minutes. This 
solution was glutamate-aspartate enriched and had a high 
concentration f potassium (20 mEq/L) to avoid prema- 
ture cardiac action (Table I). The ratio of blood to 
cardioplegia (4:1) was achieved with the Shiley BCD 
PLUS system (Mallinckrodt Medical TPI, Inc., Irvine, 
Calif.). The initial reperfusion flow was 250 ml/min or less 
to maintain a low perfusion pressure (50 to 60 mmHg) and 
a competent aortic valve. 
A retrograde perfusion cannula (Research Medical 
Retr0plegia Cannula RC-014 T, 14F, self-inflating bal- 
loon; Research Industries Corp., Midvale, Utah) was then 
introduced into the coronary sinus and fixed with a 
pursestring suture (Prolene 4-0; Ethic0n, Inc., Somerville, 
N.J.) around the coronary sinus orifice, with the knot 
Table II. Potassium chloride infusion rate 
Sertlm 
potassium 
(mEq/L) 
Retrograde infitsion flow rate (ml/hr) 
100 ml/min 150 ml/min 200 ml/min 
<4 42 63 84 
4-5 36 54 72 
5-6 30 45 60 
6-7 24 36 48 
7-8 18 27 36 
>8 12 18 24 
resting on the free wall of the right atrium, between the 
free edge and the atrioventricular junction. 
After 5 minutes of antegrade reperfusion, retrograde 
infusion was begun with normothermic oxygenated blood 
mixed with a solution of potassium chloride (0.5 mEq/ml, 
250 ml). The flow of retrograde normothermic oxygenated 
blood varied between 100 and 200 ml/min, depending on 
the size and thickness of the ventricular wall and the 
pressure reached in the coronary sinus, which was contin- 
uously monitored and kept below 50 mm Hg. 
The potassium chloride solution that was mixed with 
blood was infused continuously, with the dose based on 
the plasma level of potassium ion (which was determined 
every 15 to 20 minutes) and on the infusion rate reached 
in the retrograde perfusion, as specified in Table II, to 
maintain at all times a concentration of 20 mEq/L of 
potassium in the blood circulating through the coronary 
veins. 
The routine of implantation was then begun, and an 
aspiration line was connected tothe aortic root cannula to 
vent venous blood returning from the coronary ostia. 
Finally, the aortic anastomosis was performed, the potas- 
sium chloride infusion was discontinued, sothat once the 
suture was completed air in the cavities was expelled by 
the spontaneous heart beat. 
Parameters studied. The following data were collected 
during the preoperative period: age, sex, blood group, 
diagnosis, previous cardiac operations, tatus at the time 
of operation (at home, admitted to hospital, on ward or in 
the intensive care unit, and with or without circulatory 
assistance), urgent or elective operation, and hemody- 
namic data (mean aortic pressure, left ventricular diastolic 
pressure, pulmonary artery systolic pressure, transpulmo- 
nary gradient, pulmonary vascular resistance, cardiac out- 
put, and ejection fraction). 
With respect o the donor, the following were studied: 
the distance from donor site (local, from the community, 
or long distance), age, sex, the number of days in the 
intensive care unit, and the need for and dose (up to or 
more than 10 mg" kg -1- rain 1) of catecholamines. 
The donor was classified as suboptimum if any of the fol- 
lowing criteria existed: age older than 45 years, previous 
cardiac arrest, catecholamine use greater than 10 
mg - kg a . min 1 and weight below 80% of the recipi- 
ent's weight. 
The operative data collected were as follows: the isch- 
emic time, the time of extracorporeal circulation, and the 
time to complete all sutures (graft implantation time). We 
also observed the time to resumption of a Spontaneous 
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Table I I I .  Recipient preoperative data 
Group A Group B p 
No. of pat ients 15 22 
Age (yr) 51.5 _+ 13.4 51.4 + 14.7 NS 
Sex (n) 
Male 12 20 NS 
Female 3 2 NS 
Etiologic (n) 
Idiopathic 8 11 NS 
Ischemic 5 7 NS 
Others 2 3 NS 
Reoperation 2 4 NS 
Status 00 
At home 12 16 NS 
Urgent 3 2 NS 
ICU 1 3 NS 
Circulatory assistance 1 1 NS 
NS, Not significant; ICU, intensive care unit. 
beat after aortic declamping, problems in weaning from 
cardiopulmonary bypass ("normal," without inotropic 
drugs or with isuprel as used chronotrope, or "inotropic," 
with catecholamine support), and the presence or absence 
of spontaneous stable sinus rhythm at the end of the 
operation. 
After the operation, the mean cardiac output was 
repeatedly determined uring the first 12 hours. Hemo- 
dynamic stability was defined when patients did not need 
inotropic support. The number of days with catechol- 
amine support was also recorded. The presence or ab- 
sence of arrhythmias and their types (supraventricular or 
ventricular) and the need for temporary epicardial pace- 
maker were also observed. The peak creatine kinase level, 
total pericardial drainage, total number of transfused 
blood units, and reoperation for haemostasis or decom- 
pression were also noted. Finally, the total number of 
hours of endotracheal intubation and the intensive care 
unit and hospital stays were recorded. 
The first endomyocardial biopsy specimen (obtained 
between the seventh and the tenth postoperative days) 
was reviewed to assess the presence or absence of myofi- 
brillar necrosis without inflammatory infiltration, indica- 
tive of ischemic damage or secondary damage from cat- 
echolamines. Mortality rate within the first 30 days after 
operation was noted. Between the thirtieth and fortieth 
postoperative days, the systolic and diastolic pressures of 
the right ventricle, the ejection fraction, and the cardiac 
output were measured. 
Statistical analysis. First, the homogeneity of the pa- 
tients was determined. Once this homogeneity had been 
confirmed, studies were carried out on the relationships 
between perioperative ariables, results of the first biopsy 
(seventh to tenth postoperative day), and results of the 
first hemodynamic study (thirtieth to fortieth postopera- 
tive day) in both groups. The quantitative variables were 
expressed as mean --- standard eviation and were evalu- 
ated, after Snedecor's F variance analysis was carried out, 
by comparison of the averages of the Student's t test. The 
qualitative variables were evaluated by the X 2 test, with 
Yates' correction factor. Fisher's Exact Test was applied 
Table IV. Donor characteristics 
Group A Group B p 
Local 0z) 2 5 NS 
Community (n) l 6 NS 
At distance (n) 12 11 NS 
Age (yr) 25.4 + 10.4 25.5 ± 7.1 NS 
Sex (n) 
Male 13 18 NS 
Female 2 4 NS 
ICU stay (days) 3.5 -+ 2.5 2.3 _+ 2.6 NS 
Inotropic support (n) 
None 4 11 NS 
0-10 ~g • kg 1. rain-1 7 7 NS 
>10/xg • kg j • min -1 1 2 NS 
Suboptimum (n) 6 8 NS 
Inotropic support refers to dopamine or dobutamine infusion. NS, Not 
significant; ICU, intensive care unit. 
in those cases with an expected frequency below 5. 
Probability values below 0.05 were taken as statistically 
significant. 
Results 
No significant differences were observed in the 
following data, which show the homogeneity  for 
both groups with respect o the preoperat ive assess- 
ment of the recipient and characteristics of the 
donor  (Tables I I I  and IV). 
Recipient preoperative data. Patients in both 
groups were similar with respect o age, sex, cardiac 
diagnosis, previous operations, and preoperat ive 
status. There were no significant differences in pre- 
operat ive hemodynamic  measurements  between the 
hypothermic (group A) and the reperfusion group 
(group B). This was also true of the ejection fraction 
(26% _+ 13.2% vs 23.4% _+ 10.9%), pulmonary 
vascular esistences (3.2 _+ 1.5 Wood units vs 2.4 + 
1.3 Wood units), or t ranspulmonary gradient (7.5 _+ 
4.9 mm Hg vs 8 _+ 5.2 mm Hg). 
Donor data.  The most relevant donor data are 
summarized in Table IV. There were no significant 
differences between groups. 
Intraoperative data. The ischemic t ime in group 
B was 31 minutes less than that of group A, but the 
difference was not significant (p = 0.08; Table V). 
Continuous reperfusion of the graft (group B) car- 
r ied a certain degree of technical difficulty, which 
was ref lected in the longer (by 12 minutes) t ime 
needed to complete the suture lines (67.3 minutes vs 
55.3 minutes; p = 0.009), but the t ime on extracor- 
poreal  circulation for both groups was the same (125 
minutes), as was the overall  t ime for implantat ion of 
the heart. 
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In Fig. 1, the different surgical times (ischemia, 
suture, reperfusion, and extracorporeal circulation 
times) are represented. The time spent in the harvest- 
ing and transportation is the same in both groups, and 
the cardiopulmonary b pass time was also the same. 
Several differences were found. In group A, after a 
short period of trimming, we performed the implanta- 
tion in 55.3 minutes. The heart was then reperfused, 
the total ischemic time was 178.8 minutes. In group B, 
trimming took longer because of the introduction of 
the canulas and the administration f the initial reper- 
fusion. However the total ischemic time was 147.7 
minutes, 31 minutes less than in group A. Implantation 
was performed in 67.3 minutes, while the heart was 
reperfused with controlled pressure and flow, in a 
systole at normothermia and with ventricles empty 
(Fig. 1). After release of the aortic crossclamp, the 
heart resumed a spontaneous rhythm in only two cases 
in group A. In contrast, in Group B spontaneous 
resumption ocurred in practically all cases (20/22; p < 
0.001). With respect o weaning from extracorporeal 
circulation, there were no differences in the need for 
inotropic support (four cases in group A and six in 
group B), although there was a tendency toward 
greater stability of sinus rhythm in the reperfusion 
group (p = 0.08; Table V). 
Postoperative data. Cardiac output and hemody- 
namic stability in the first 12 hours after operation 
were similar in the two groups (Table VI). On the 
other hand, the number of days that inotropic 
support for cardiac function or rate was necessary 
was significantly ower in group B (3.1 days) than in 
group A (6 days; p = 0.02). The incidence of 
arrhythmia was also significantly lower in group B 
(8/22) versus group A (11/15; p = 0.04). 
Differences were not found in maximum creatine 
kinase levels, pericardial drainage, or transfused 
units of blood. There were no differmaces in the 
number of hours of endotracheal intubation or in 
in-hospital mortality rate. The causes of death were 
early graft failure for one patient in group A and 
one patient in group B and multiorgan failure in the 
other two patients in group B who died (Table VI). 
None of the patients in group B had more clinical or 
hemodynamic evidence of right ventricular dysfunc- 
tion than seen in group A patients. 
On the other hand, there was a significant differ- 
ence in length of intensive care unit and hospital 
stays, which were significantly less for group B than 
for group A (p < 0.0001 andp < 0.01, respectively). 
There was no change in medical management of
patients during this time period. 
Table V. Intraoperative data 
Group A Group B p 
Ischemic time (min) 
CPB time (rain) 
Suture time (rain) 
Spontaneous beating (n) 
Weaning from CPB (n) 
Normal 
Inotropic support 
Stable SR 
178.8 -+ 55.1 147.7 + 61.2 0.08 
125 -+ 72.3 124.2 ± 40 NS 
53.3 -+ 18.7 67.3 -- 15.9 0.009 
2 20 <0.001 
11 16 NS 
4 6 NS 
8 18 0.08 
CPB, Cardiopulmonary b pass; NS, not significant; SR, sinus rhythm. 
In all endomyocardial biopsy samples obtained 
between the seventh and tenth postoperative days in 
group A, isolated foci of myofibrilar necrosis of 
ischemic origin were found. No evidence of ischemia 
was noted in nine (45%) of the 20 biopsy samples 
obtained in group B (p < 0.01). 
Hemodynamic studies done on the thirtieth and 
fortieth postoperative days showed significantly 
lower right ventricular pressures, both systolic and 
diastolic, in group B (p = 0.03 and p = 0.04, 
respectively) compared with group A. There were 
no differences in ejection fraction and cardiac out- 
put, which were normal in both groups (Table VII). 
Discussion 
This continuous warm reperfusion technique is an 
attempt at reducing as much as possible ischemic 
time and reperfusion damage in an effort to "res- 
cue" areas of the myocardium that were not irre- 
versibly damaged by storage of the donor heart. It is 
known that the conditions under which reperfusion 
is carried out are of great importance. Allen, Oka- 
moto, and Buckberg 19 and Okamato and col- 
leagues 2° showed that in coronary artery operations, 
myocardial contractility is preserved after prolonged 
ischemic periods, if reperfusion is performed with 
low pressure and flow, even more so if reperfusion is
carried out for 10 minutes. Chambers, Takahashi, 
and Hearse 23 came to the same conclusions regard- 
ing experimental heart transplants perfused under 
hypothermia. Kirklin and associates 11have recom- 
mended that the pressure in the aortic root should 
not exceed 60 mm Hg when reperfusion in human 
heart transplantation is carried out under normo- 
thermia with blood cardioplegia. 
We tried to reduce the temperature gradient 
between the reperfused blood and the myocardium. 
This allowed a progressive rewarming of the graft 
after its removal from the refrigerator, maintenance 
at room temperature during trimming, and mainte- 
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Fig. 1. Schematic representation of the different surgical times (minutes) in groups A (A) and B (B). 
Table VI. Postoperative data 
Group A Group B p 
Cardiac output (L/min) 6.4 -- 1.2 7.3 -+ 1.9 NS 
Hemodynamic stability (n) 11 10 NS 
Inotropic support (days) 6 _+ 2.3 3.1 _+ 1.1 <0.02 
Arrhythmias 00 
None 4 14 <0.04 
Supraventricular 4 2 NS 
Ventricular 3 1 NS 
Pacemaker required 4 5 NS 
Creatine kinase (units) 1188 _+ 639 1006 _+ 523 NS 
Total drainage (ml) 1450 +_ 1291 1367 _+ 1106 NS 
Blood transfused (units) 4.8 _+ 5.5 2.7 _+ 2.4 NS 
Reoperation (n) 3 3 NS 
Mechanical ventilation 24.7 +_ 23.1 23.6 +_ 27.2 NS 
(hr) 
ICU stay (days) 7.4 _+ 2.1 4.7 +_ 1.4 <0.0001 
Hospital stay (days) 15.6 _+ 5 10.7 _+ 3.6 <0.01 
No ischemia t first endo- 0 9 (45%) <0.01 
myocardial biopsy (n) 
Hospital mortality (n) 1 3 NS 
NS, Not significant; ICU, intensive care unit. 
nance at room temperature thereafter by infusion of 
the initial dose of perfusate at 30 ° to 32 ° C. 
With respect to the composition of the reperfu- 
sion solution, in the initial dose we use the same 
solution as that of Buckberg, 1° but with a high 
concentration of potassium TM 24 to maintain asystole 
Table VII. Cardiac catheterization, first 
postoperative month 
Group A Group B p 
Right ventricular systolic 36.7 + 11.9 26.6 _+ 6.4 <0.003 
pressure (mmHg) 
Right ventricular diastolic 5.5 _+ 12.5 3.5 _+ 2.6 <0.04 
pressure (mmHg) 
Ejection fraction (%) 64.7 -+ 6.1 64.6 -+ 11.2 NS 
Cardiac output (L/min) 6.9 _+ 2.2 6 _+ 1.2 NS 
during the initial phase of implantation. The addi- 
tion of substrates uch as glutamate seems to im- 
prove recovery of ventricular function after pro- 
longed ischemia in conventional operations 7' 9 as 
well as in heart transplantation after cold storage, s 
We chose the retrograde route for cardioplegia 
administration because it does not interfere with the 
construction of the anastomoses. There is thus as- 
surance of continuous perfusion throughout he 
procedure. If antegrade cardioplegia is used, it is 
necessary to maintain aortic valve competence. Per- 
fusion has to be discontinued uring the aortic 
anastomosis, which leads to a period of normother- 
mic ischemia nd possible reperfusion damage. The 
hemodynamic performance of the right ventricle 1 
month after operation appeared better than that 
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observed with the conventional technique, suggest- 
ing adequate distribution of flow with retrograde 
cardioplegia. 
With continuous reperfusion of the graft with oxy- 
genated blood under normothermia during cardiac 
implantation, reduction of ischemic time was achieved, 
as shown by Menasch6,14 who begins reperfusion after 
suture of the left atrium. With our technique, ischemia 
is further reduced (up to 30 minutes in total) if 
reperfusion is begun at the moment of the graft's 
removal from the refrigerator. This makes it possible 
to increase the safe time span for procurement and 
enlarges the pool of possible donors. 
The greater complexity of the technique implies 
lengthening the suture time for the graft by 12 
minutes. There is no increase in the cardiopulmo- 
nary bypass time, however, and the hemostatic 
quality of the sutures appears not to be jeopardized, 
because the total volume of bleeding and the fre- 
quency of reoperation remain the same. 
Surgeons who use intermittent doses of cold 
blood cardioplegia during implantation and subse- 
quent reperfusion with warm blood cardioplegia 
have found this method superior to the conventional 
technique with respect o the incidence of sponta- 
neous defibrillation, return to sinus rhythm, time of 
mechanical ventilation, and the need for, dosage of, 
and duration of dopamine administration. 12'13 We 
observed spontaneous return of cardiac function in 
90.9% of cases. The hemodynamic status at time of 
weaning from bypass was similar to that noted with 
the conventional technique. On the other hand, 
stable sinus rhythm resumed at the end of the 
operation when reperfusion was used, associated 
with a lower incidence of arrhythmias after opera- 
tion.12, 13 The duration of catecholamine adminis- 
tration was reduced with continuous reperfusion. 
There was no change, however, in the number of 
hours of mechanical ventilation, as observed by 
others.12, 13 Intensive care unit and hospital stays are 
reduced when continuous normothermic reperfu- 
sion is used. There was no difference in mortality 
rate in the first 30 days between hypothermic and 
normothermic groups. 
Although operative mortality rate, transmural in- 
farction, need for defibrillation, and need for ino- 
tropic support or counterpulsation are nonspecific 
and insensitive indicators of myocardial damage, 25 
these parameters are cited in the various studies in 
the literature. To improve the reliability of these 
studies, it would be necessary to carry out serial 
enzymatic determinations, radioisotope ventricular 
function studies, and regional ventricular wall mo- 
tion studies with transesophageal chocardiography. 
These studies are difficult to perform because of the 
logistic complexity, involving the donor hospital and 
later follow-up at another institution where the 
heart is implanted. 
Conclusions 
It is technically feasible to perform cardiac trans- 
plantation with continuous coronary perfusion dur- 
ing implantation of the heart. The ischemic time is 
reduced, with consequent increase in the donor pool 
availability. Defibrillation and return to spontane- 
ous sinus rhythm ocurred in most of the cases. There 
was a lower incidence of arrhythmias in the normo- 
thermic group during the immediate postoperative 
period. There was evidence of less ischemia in the 
first endomyocardial biopsy specimen. One month 
after operation, the right ventricular pressures were 
lower. Echocardiographic studies before and after 
harvesting could confirm the superiority of continu- 
ous coronary perfusion during implantation, allow- 
ing the surgeon to "rescue" donor hearts usually 
rejected for use in cardiac transplantation. 
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